Limited resections for duodenal gastrointestinal stromal tumors and their oncologic outcomes
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chung, Jun Chul | - |
dc.contributor.author | Kim, Hyung Chul | - |
dc.contributor.author | Hur, Sung Mo | - |
dc.date.accessioned | 2021-08-11T18:24:45Z | - |
dc.date.available | 2021-08-11T18:24:45Z | - |
dc.date.issued | 2016-01 | - |
dc.identifier.issn | 0941-1291 | - |
dc.identifier.issn | 1436-2813 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/9473 | - |
dc.description.abstract | Purpose Limited resection is considered a treatment option for duodenal gastrointestinal stromal tumors (GISTs) whenever technically feasible, but the optimal technique for this is still not well defined. We present the various types of limited resections for duodenal GISTs and analyze their postoperative outcomes. Methods The subjects of this retrospective clinicopathologic analysis were 21 patients who underwent limited resections for duodenal GIST between May, 2001 and June, 2014. The median follow-up period was 52 months (range 5-125 months). Results The patients comprised 12 men and 9 women, with a median age of 59 years (range 45-75 years), all of whom were treated by various forms of limited resection with clear margins. There were ten wedge resections with primary closure (eight open/two laparoscopic), two wedge resections with Roux-en Y duodenojejunostomy, three segmental duodenectomies with end-to-end duodenoduodenostomy, and six segmental duodenectomies with end-to-end duodenojejunostomy. Hepatic metastasis was found 27 months after surgery in one patient, who was given imatinib mesylate for 17 months to slow disease progression. The other 20 patients were alive and recurrence free at the time of writing. Conclusion Excellent recurrence-free survival was achieved after limited resections, supporting the consideration of various methods of limited resection as the treatment of choice for duodenal GISTs. | - |
dc.format.extent | 7 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | Springer Verlag | - |
dc.title | Limited resections for duodenal gastrointestinal stromal tumors and their oncologic outcomes | - |
dc.type | Article | - |
dc.publisher.location | 미국 | - |
dc.identifier.doi | 10.1007/s00595-015-1163-x | - |
dc.identifier.scopusid | 2-s2.0-84949223051 | - |
dc.identifier.wosid | 000369914600014 | - |
dc.identifier.bibliographicCitation | Surgery Today, v.46, no.1, pp 110 - 116 | - |
dc.citation.title | Surgery Today | - |
dc.citation.volume | 46 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 110 | - |
dc.citation.endPage | 116 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Surgery | - |
dc.relation.journalWebOfScienceCategory | Surgery | - |
dc.subject.keywordPlus | IMATINIB MESYLATE | - |
dc.subject.keywordPlus | ADJUVANT IMATINIB | - |
dc.subject.keywordPlus | MANAGEMENT | - |
dc.subject.keywordPlus | DUODENECTOMY | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordAuthor | Gastrointestinal stromal tumor | - |
dc.subject.keywordAuthor | Duodenum | - |
dc.subject.keywordAuthor | Surgery | - |
dc.subject.keywordAuthor | Limited resection | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.